[Federal Register Volume 85, Number 233 (Thursday, December 3, 2020)]
[Notices]
[Pages 78132-78133]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26631]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-1074]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Colorectal Cancer Control (CRCCP) Monitoring 
Activities to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on June 5, 
2020 to obtain comments from the public and affected agencies. CDC 
received two non-substantive public comments and provided responses to 
each. This notice serves to allow an additional 30 days for public and 
affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Colorectal Cancer Control Program (CRCCP) Monitoring Activities 
(OMB Control No. 0920-1074, Exp. 7/31/2020)--Reinstatement with 
Change--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a Reinstatement with Change to OMB Control No. 
0920-1074. CDC proposes use of a modified annual grantee survey 
instrument (renamed ``Annual Awardee Survey''), a modified clinic-level 
data collection instrument, and a new awardee-level Quarterly Program 
Update. The number of respondents will increase from 30 to 35 awardees, 
and the total estimated annualized burden will increase.
    Colorectal cancer (CRC) is the second leading cause of death from 
cancer in the United States among cancers that affect both men and 
women. There is substantial evidence that CRC screening reduces the 
incidence of and death from the disease. Screening for CRC can detect 
disease early, when treatment is more effective, and prevent cancer by 
finding and removing precancerous polyps. Of individuals diagnosed with 
early stage CRC, more than 90% live five or more years. To reduce CRC 
morbidity, mortality, and associated costs, use of CRC screening tests 
must be increased among age-eligible adults with the lowest CRC 
screening rates.
    The purpose of the Colorectal Cancer Control Program (CRCCP) is to 
partner with health systems and their individual primary care clinics 
to implement evidence-based interventions (EBIs) to increase CRC 
screening among defined populations of adults ages 50-75 that have CRC 
screening rates lower than the national, regional, or local rate.
    In 2020, CDC issued a new funding opportunity, Public Health and 
Health System Partnerships to Increase Colorectal Cancer Screening in 
Clinical Settings (DP20-2002), a five-year cooperative agreement to 
increase CRC screening among defined populations of adults ages 50-75 
that have CRC screening rates lower than the national, regional, or 
local rate. DP20-2002 funds recipients to partner with health systems 
and their primary care clinics to implement multiple EBIs, partner with 
organizations to support implementation of EBIs in those clinics, and 
collect high-quality clinic-level data when a clinic is recruited to 
participate (baseline) and annually thereafter to monitor EBI 
implementation and assess screening rate changes. DP20-2002 eliminates 
funding to provide direct clinical service delivery. However, DP20-2002 
requires recipients to conduct a formal readiness assessment of 
potential clinics to implement EBIs, use assessment findings to select 
appropriate EBIs for implementation, and provide clinics with limited 
financial resources to support follow-up colonoscopies for under- and 
uninsured patients after an abnormal CRC screening test.
    CDC proposes three information collections--a modified Annual 
Awardee Survey, a modified Clinic-Level Data Collection Instrument, and 
a new awardee-level Quarterly Program Update--to reflect modified goals 
for the new cooperative agreement and a modified monitoring plan.
    The Annual Awardee Survey eliminates questions related to clinic 
service delivery, which is no longer funded under DP20-2002. In 
addition, many program management questions were eliminated and will 
now be gathered via the Quarterly Program Update on a quarterly basis 
to better inform CDC technical assistance (TA). The survey now includes 
five items regarding the effect of COVID-19 on CRCCP implementation at 
the grantee level.
    The modified clinic-level data collection instrument was 
reorganized for increased efficiency and overall data quality 
improvement. In addition, wording and responses for many variables and 
their response options have undergone minor revisions to better capture 
awardees' partnerships with both health systems and clinics, and 
appropriate capture of baseline and annual variables. The instrument 
gathers information to assess health system and clinic characteristics; 
program reach; CRC screening practices and outcomes; clinics' quality 
improvement and monitoring activities;

[[Page 78133]]

EBI implementation; additional factors that affect EBI implementation 
over time; and the effect of COVID-19 on CRCCP implementation at the 
clinic level.
    The new Quarterly Program Update survey will collect standardized 
awardee-level information on aspects of program management, including 
(1) respondent information, (2) award spending, (3) staff vacancies, 
(4) program successes and challenges, (5) TA needs, and (6) COVID-19. 
This information collection will provide CDC staff rapid reporting of 
programmatic information to inform their efforts to provide awardees 
with tailored TA.
    Redesigned data elements will enable CDC to better gauge progress 
in meeting CRCCP program goals and monitor implementation activities, 
evaluate outcomes, and identify awardee TA needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded.
    OMB approval is requested for three years. The number of awardees 
will increase from 30 to 35 awardees, and the number of clinic partners 
is expected to increase from 12 to 24 per awardee. Therefore, the total 
estimated annualized burden hours have increased from 204 to 760 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent          hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Awardees........................  CRCCP Annual Awardee                  35               1           15/60
                                         Survey.
                                        CRCCP Clinic-level Data               35              24           50/60
                                         Collection Instrument.
                                        CRCCP Quarterly Program               35               4           22/60
                                         Update.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2020-26631 Filed 12-2-20; 8:45 am]
BILLING CODE 4163-18-P